Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal

Bram L. T. Ramaekers*, Rob Riemsma, Florian Tomini, Thea van Asselt, Sohan Deshpande, Steven Duffy, Nigel Armstrong, Johan L. Severens, Jos Kleijnen, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)191-202
Number of pages12
JournalPharmacoeconomics
Volume35
Issue number2
DOIs
Publication statusPublished - Feb 2017

Keywords

  • PLACEBO-CONTROLLED PHASE-3
  • SURVIVAL ANALYSIS
  • DOUBLE-BLIND

Cite this